Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting, 85550 [2024-24982]

Download as PDF 85550 Federal Register / Vol. 89, No. 208 / Monday, October 28, 2024 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting lotter on DSK11XQN23PROD with NOTICES1 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Board on Medical Rehabilitation Research. This will be a hybrid meeting held inperson and virtually and will be open to the public as indicated below. Individuals who plan to attend inperson or view the virtual meeting and need special assistance or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting can be accessed from the NIH Videocast at the following link: https:// videocast.nih.gov/. Name of Committee: National Advisory Board on Medical Rehabilitation Research. Date: December 2–3, 2024. Time: December 02, 2024, 10:00 a.m. to 5:00 p.m. Agenda: NICHD Director’s Report, NCMRR Director’s report; NABMRR Liaison to NICHD Advisory Council Report; Scientific Talk on Collaboration; Report from the NIH Disability Research Coordinating Committee; Scientific Talk on Bilateral Task Training Post Stroke; Updates on the NIH Research Plan on Rehabilitation; Nominations for next Chair. Address: Eunice Kennedy Shriver National Institute of Child Health and Human Development, 6710B Rockledge Drive, Bethesda, MD 20817 (In Person and Virtual Meeting). Time: December 03, 2024, 10:00 a.m. to 2:00 p.m. Agenda: Implementation of the NIH’s Simplified Review Framework; Scientific Talk on BCI; Election of Chair; Talk on Community Engagement in Research; Planning for next meeting in May 2025. Address: Eunice Kennedy Shriver National Institute of Child Health and Human Development, 6710B Rockledge Drive, Bethesda, MD 20817 (In Person and Virtual Meeting). Contact Person: Ralph M. Nitkin, Ph.D., Deputy Director, National Center for Medical Rehabilitation, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, 6710B Rockledge Drive, Room 2116, Bethesda, MD 20892– 7510, (301) 402–4206, nitkinr@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Persons listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this VerDate Sep<11>2014 19:13 Oct 25, 2024 Jkt 265001 notice at least 10 days in advance of the meeting. Interested individuals and representatives of an organization may submit a letter of intent, a brief description of the organization represented and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors attending a meeting on campus or at an off-campus federal facility will be asked to show one form of identification (for example, a governmentissued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// www.nichd.nih.gov/about/advisory/nabmrr, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: October 22, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–24982 Filed 10–25–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention’s (CSAP) Drug Testing Advisory Board (DTAB) will convene via web conference on December 3, 2024, from 10 a.m. EST to 2:30 p.m. EST. The board will meet in open session December 3, 2024, from 10 a.m. EST to 2:30 p.m. EST to hear updates from the Department of Transportation (DOT), PO 00000 Frm 00063 Fmt 4703 Sfmt 9990 the Department of Defense (DoD) and the Nuclear Regulatory Commission (NRC), and updates from HHS on the Federal Workplace Drug Testing Program and Mandatory Guidelines. Additionally, the board will hear presentations regarding a collaboration between the Department of Defense and the Division of Workplace Programs as well as data presented for consideration regarding evaluation of the cutoff for an invalid pH result in urine. Data provided by HHS-certified laboratories indicates that invalid urine pH results cycle with the seasonal temperature fluctuations. Data will be presented to facilitate and inform decisions regarding a possible adjustment in the cutoff for urine pH to reduce this cyclical effect while continuing to identify potential tampering of specimens. Meeting registration information can be completed at https:// snacregister.samhsa.gov/. Web conference and call information will be sent after completing registration. Meeting information and a roster of DTAB members may be obtained by accessing the SAMHSA Advisory Committees website, https:// www.samhsa.gov/about-us/advisorycouncils/meetings, or by contacting the Designated Federal Officer, Lisa Davis. Committee Name: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Prevention, Drug Testing Advisory Board. Dates/Time/Type: December 3, 2024, from 10:00am EST to 2:30pm EST: Open. Place: Virtual. To Submit Comments: Requests to make public comment during the public comment period of the December DTAB meeting must be made in writing at least 7 days prior to the meeting to the following email: DFWP@ samhsa.hhs.gov. Contact: Lisa S. Davis, M.S, Social Science Analyst, Center for Substance Abuse Prevention, 5600 Fishers Lane, Rockville, Maryland, 20857, Telephone: (240) 276–1440, Email: Lisa.Davis@ samhsa.hhs.gov. Anastasia Flanagan, Public Health Advisor, Division of Workplace Programs. [FR Doc. 2024–24972 Filed 10–25–24; 8:45 am] BILLING CODE 4162–20–P E:\FR\FM\28OCN1.SGM 28OCN1

Agencies

[Federal Register Volume 89, Number 208 (Monday, October 28, 2024)]
[Notices]
[Page 85550]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24982]



[[Page 85550]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health & Human 
Development; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Advisory 
Board on Medical Rehabilitation Research.
    This will be a hybrid meeting held in-person and virtually and will 
be open to the public as indicated below. Individuals who plan to 
attend in-person or view the virtual meeting and need special 
assistance or other reasonable accommodations, should notify the 
Contact Person listed below in advance of the meeting. The meeting can 
be accessed from the NIH Videocast at the following link: https://videocast.nih.gov/.

    Name of Committee: National Advisory Board on Medical 
Rehabilitation Research.
    Date: December 2-3, 2024.
    Time: December 02, 2024, 10:00 a.m. to 5:00 p.m.
    Agenda: NICHD Director's Report, NCMRR Director's report; NABMRR 
Liaison to NICHD Advisory Council Report; Scientific Talk on 
Collaboration; Report from the NIH Disability Research Coordinating 
Committee; Scientific Talk on Bilateral Task Training Post Stroke; 
Updates on the NIH Research Plan on Rehabilitation; Nominations for 
next Chair.
    Address: Eunice Kennedy Shriver National Institute of Child 
Health and Human Development, 6710B Rockledge Drive, Bethesda, MD 
20817 (In Person and Virtual Meeting).
    Time: December 03, 2024, 10:00 a.m. to 2:00 p.m.
    Agenda: Implementation of the NIH's Simplified Review Framework; 
Scientific Talk on BCI; Election of Chair; Talk on Community 
Engagement in Research; Planning for next meeting in May 2025.
    Address: Eunice Kennedy Shriver National Institute of Child 
Health and Human Development, 6710B Rockledge Drive, Bethesda, MD 
20817 (In Person and Virtual Meeting).
    Contact Person: Ralph M. Nitkin, Ph.D., Deputy Director, 
National Center for Medical Rehabilitation, Eunice Kennedy Shriver 
National Institute of Child Health and Human Development, NIH, 6710B 
Rockledge Drive, Room 2116, Bethesda, MD 20892-7510, (301) 402-4206, 
[email protected].

Any interested person may file written comments with the committee 
by forwarding the statement to the Contact Persons listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation 
of the interested person.
    Any member of the public interested in presenting oral comments 
to the committee may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of an organization may submit a letter of 
intent, a brief description of the organization represented and a 
short description of the oral presentation. Only one representative 
of an organization may be allowed to present oral comments and 
presentations may be limited to five minutes. Both printed and 
electronic copies are requested for the record. In addition, any 
interested person may file written comments with the committee by 
forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation 
of the interested person.
    In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for 
entrance into on-campus and off-campus facilities. All visitor 
vehicles, including taxicabs, hotel, and airport shuttles will be 
inspected before being allowed on campus. Visitors attending a 
meeting on campus or at an off-campus federal facility will be asked 
to show one form of identification (for example, a government-issued 
photo ID, driver's license, or passport) and to state the purpose of 
their visit.
    Information is also available on the Institute's/Center's home 
page: https://www.nichd.nih.gov/about/advisory/nabmrr, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: October 22, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-24982 Filed 10-25-24; 8:45 am]
BILLING CODE 4140-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.